View Author
scopus: 7101854258

Masera, G.

( G. Masera)


patient group leukemia target study lymphoblastic leukemia treatment children t-all childhood paediatric rearrangement cancer result disease lymphoblastic analysis fication level precursor b-all mrd levels oncology trial sensitivity research rq-pcr precursor b-all germany detection mrd-based sample laboratory strati protocol european vaccination diagnosis point therapy figure paediatric oncology mrd analysis mrd-based strati fication varicella follow-up outcome blood time points identi vzv vaccination receptor van dongen jj lymphoblastic leukaemia van wering vzv infection mrd results university interpretation austria month response multicentric identi fied dongen infection enrollment relapse mrd level italy rq-pcr data van dongen jjm center europe interventional velden randomised death number information




6 Most Recent Publications

The controversy of varicella vaccination in children with acute lymphoblastic leukemia (Article)
Caniza, M.A. Hunger, S.P. Liang, D. Ohara, A. Okamura, J. Pieters, R. Schmiegelow, K. Schrappe, M. Stark, B. Stary, J. Schrauder, A. Valsecchi, M.G. Pui, C.H. Masera, G. Baruchel, A. Biondi, A. Devidas, M. Horibe, K.
2012-01-01
Editorial: Educational symposium on long-term results of large prospective clinical trials for childhood acute lymphoblastic leukemia (1985-2000) (Article)
Schrappe, M. Nachman, J. Hunger, S.P. Schmiegelow, K. Conter, V. Masera, G. Pieters, R. Pui, C.H.
2010-02-01
Imperative of continual support by the European Community for future advances in paediatric oncology in Europe: Meeting report of the EC-funded science-communication project DIRECT "Overcoming Cancer with Research" (Article)
Tallen, G. Dworzak, M.N. Creutzig, U. Gadner, H. Masera, G. Schrappe, M. Biondi, A. Vassal, G. Pieters, R. Jazbec, J. Morland, B.
2009-12-01
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia (Article)
Flohr, T. Schrauder, A. Sutton, R. Koehler, R. Zimmermann, M. Valsecchi, M.G. Gadner, H. Masera, G. Schrappe, M. Dongen, J.J.M. van Biondi, A. Bartram, C.R. Cazzaniga, G. Panzer-Grümayer, R. Velden, V.H.J. van der Fischer, S. Stanulla, M. Basso, G. Niggli, F. Schäfer, B.W.
2008-04-01
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting (Article)
Velden, V.H.J. van der Panzer-Grümayer, E.R. Bartram, C.R. Masera, G. Biondi, A. Dongen, J.J.M. van Cazzaniga, G. Flohr, T. Sutton, R. Schrauder, A. Basso, G. Schrappe, M. Wijkhuijs, J.M. Konrad, M.
2007-04-01
Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL (Article)
Willemse, M.J. Hop, W.C.J. Gadner, H. Seriu, T. Hettinger, K. Aniello, E. d' Panzer-Grumayer, E.R. Biondi, A. Dongen, J.J.M. van Schrappe, M. Kamps, W.A. Bartram, C.R. Masera, G. Riehm, H.
2002-01-01